Literature DB >> 10817589

Expression of angiotensin II AT2 receptor in the acute phase of stroke in rats.

Y Z Zhu1, G N Chimon, Y C Zhu, Q Lu, B Li, H Z Hu, E H Yap, H S Lee, P T Wong.   

Abstract

A male Wistar rat model of stroke (middle cerebral artery occlusion; MCAO) was used to study the angiotensin II (Ang II) receptor subtype 2 (AT2) gene expression by reverse transcription polymerase chain reaction (RT-PCR) and immunohistochemical staining. After permanent occlusion of the middle cerebral artery (MCA), AT2 receptor gene expression was found to increase in the infarct cortex by 2.7-fold (1 day) and 1.7-fold (3 days), respectively. Positive AT2 immunostaining was also observed in the infarct area of the cerebral cortex. Apoptotic markers were detected in the necrotic area of the stroke cerebral cortex 1 day after MCAO. This demonstrated up-regulation of AT2 receptor may be involved in the apoptosis of tissue repair after stroke.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10817589     DOI: 10.1097/00001756-200004270-00009

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  12 in total

Review 1.  Angiotensin AT2 receptor ligands: do they have potential as future treatments for neurological disease?

Authors:  Philip Rosenstiel; Stefan Gallinat; Alexander Arlt; Thomas Unger; Jobst Sievers; Ralph Lucius
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

Review 2.  Role of angiotensin II receptor subtype activation in cognitive function and ischaemic brain damage.

Authors:  Masatsugu Horiuchi; Masaki Mogi
Journal:  Br J Pharmacol       Date:  2011-07       Impact factor: 8.739

3.  Prevention of pulmonary hypertension by Angiotensin-converting enzyme 2 gene transfer.

Authors:  Yoriko Yamazato; Anderson J Ferreira; Kwon-Ho Hong; Srinivas Sriramula; Joseph Francis; Masanobu Yamazato; Lihui Yuan; Chastity N Bradford; Vinayak Shenoy; Suk P Oh; Michael J Katovich; Mohan K Raizada
Journal:  Hypertension       Date:  2009-06-29       Impact factor: 10.190

4.  Cardiovascular effect of inflammation and nonsteroidal anti-inflammatory drugs on renin-angiotensin system in experimental arthritis.

Authors:  Waheed Asghar; Ali Aghazadeh-Habashi; Fakhreddin Jamali
Journal:  Inflammopharmacology       Date:  2017-04-07       Impact factor: 4.473

Review 5.  Macrophages in neuroinflammation: role of the renin-angiotensin-system.

Authors:  Anna Hammer; Johannes Stegbauer; Ralf A Linker
Journal:  Pflugers Arch       Date:  2017-02-11       Impact factor: 3.657

6.  Moderate cardiac-selective overexpression of angiotensin II type 2 receptor protects cardiac functions from ischaemic injury.

Authors:  Yanfei Qi; Hongwei Li; Vinayak Shenoy; Qiuhong Li; Fong Wong; Ling Zhang; Mohan K Raizada; Colin Sumners; Michael J Katovich
Journal:  Exp Physiol       Date:  2011-10-03       Impact factor: 2.969

7.  Direct stimulation of angiotensin II type 2 receptor enhances spatial memory.

Authors:  Fei Jing; Masaki Mogi; Akiko Sakata; Jun Iwanami; Kana Tsukuda; Kousei Ohshima; Li-Juan Min; Ulrike M Steckelings; Thomas Unger; Björn Dahlöf; Masatsugu Horiuchi
Journal:  J Cereb Blood Flow Metab       Date:  2011-10-05       Impact factor: 6.200

8.  Cell atavistic transition: Paired box 2 re-expression occurs in mature tubular epithelial cells during acute kidney injury and is regulated by Angiotensin II.

Authors:  Yushen Jiang; Tang Jiang; Juan Ouyang; Qingsong Zhou; Yanlan Liang; Yingpeng Cui; Peisong Chen; Bin Huang
Journal:  PLoS One       Date:  2014-04-07       Impact factor: 3.240

Review 9.  Therapeutic potential of the renin angiotensin system in ischaemic stroke.

Authors:  Mariana Moreira Coutinho Arroja; Emma Reid; Christopher McCabe
Journal:  Exp Transl Stroke Med       Date:  2016-10-07

Review 10.  AT2 receptors: functional relevance in cardiovascular disease.

Authors:  Emma S Jones; Antony Vinh; Claudia A McCarthy; Tracey A Gaspari; Robert E Widdop
Journal:  Pharmacol Ther       Date:  2008-08-31       Impact factor: 12.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.